Cleared Traditional

K191179 - Myo Plus

K191179 is an FDA 510(k) clearance for Myo Plus, manufactured by Otto Bock Healthcare Products GmbH. The device is a Class 2 Neurology device with product code GXY cleared through the Traditional 510(k) pathway after a 125-day FDA review.

K191179 · Otto Bock Healthcare Products GmbH · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 2019
Decision
125d
Days
Class 2
Risk

K191179 is an FDA 510(k) clearance for the Myo Plus. Classified as Electrode, Cutaneous (product code GXY), Class II - Special Controls.

Submitted by Otto Bock Healthcare Products GmbH (Vienna, AT). The FDA issued a Cleared decision on September 4, 2019 after a review of 125 days - within the typical 510(k) review window.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.1320 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Neurology review framework, consistent with the majority of Class II 510(k) submissions.

View all Otto Bock Healthcare Products GmbH devices

FDA 510(k) Submission Details - K191179

510(k) Number K191179 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 02, 2019
Decision Date September 04, 2019
Days to Decision 125 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
23d faster than avg
Panel avg: 148d · This submission: 125d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GXY Device Classification - Class 2, Special Controls

Product Code GXY Electrode, Cutaneous
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.1320
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - GXY Electrode, Cutaneous

All 290
Devices cleared under the same product code (GXY) and FDA review panel - the closest regulatory comparables to K191179.
Dr-Ho's Foot Pad Electrode (Models: DHFRE-I, CP-I, CP-II, CP-III)
K190118 · Guangzhou Xinbo Electronic Co., Ltd. · May 2020
Disposable EEG Electrodes (MODEL: DL, E-CAP, FLEX-CAP)
K200162 · Wuhan Greentek Pty , Ltd. · Apr 2020
Disposable Gold Cup EEG Electrodes
K192564 · Dymedix Diagnostics, Inc. · Jan 2020
EEG Electrode Template
K191225 · Rhythmlink International, LLC · Aug 2019
Wrap accessory electrodes
K190617 · Hi-Dow International, Inc. · Jul 2019
ELECTRODES PAD
K190700 · Shenzhen Bestpad Technology Development Co., Ltd. · Jun 2019